Jiangzhou Shi

Establishment of a New Cryopreservation Solution for Chimeric Antigen Receptor T Cells.

Yao Xu, Hai-Yong Zhu, Tongcun Zhang, 2022, Biopreservation and biobanking.

The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity

K. Young, Yong Zhou, Tongcun Zhang, 2022, Scientific Reports.

Modulation of Foxo1/Foxo3 Stability in Function of Regulatory T Cells through Regulate Development and Mst1/Mst2

W. Tao, Zengqiang Yuan, Y. Zhuang, 2022 .

CAR T cells targeting CD99 as an approach to eradicate T-cell acute lymphoblastic leukemia without normal blood cells toxicity

F. Zhou, Zhe Li, Zijian Zhang, 2021, Journal of Hematology & Oncology.

Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment.

H. Gong, P. Jiang, Xinxiang Zhang, 2023, Cell metabolism.

ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming

Xiao-Yu Zhang, Anwen Ren, Tong-Cun Zhang, 2023, Acta Pharmacologica Sinica.